在英国,驾驶障碍者立法的发展和现状
1Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Forensic science review
|February 1, 2025
概括
英国关于在酒后驾驶 (DUI) 的立法发生了重大变化,在1967年引入了固定的酒精限量和2015年引入了药物度限量. 这些法律将起诉从证明损害转移到超过法定限制.
科学领域:
- 法医科学 法医科学 法医科学
- 法律研究 法律研究
- 公共卫生 公共卫生
背景情况:
- 在英国,对酒后驾驶 (DUI) 的立法已经发生了重大发展.
- 早期的法律要求证明损害,这是一个挑战,以始终地建立.
研究的目的:
- 追踪英国有关酒精 (DUI) 和其他毒品 (DUID) 影响下的驾驶立法的演变.
- 检查关键立法变革对起诉和执法的影响.
主要方法:
- 对英国立法进行历史分析,重点关注1967年"道路安全法"及其后续修正案.
- 对酒精和毒品的法定度限值的引入进行审查.
- 检查路边检测和收集证据的警察程序的变化.
主要成果:
- 1967年"道路安全法"制定了法定血液和尿液酒精度限制,将起诉的重点从损害转移到超过限制.
- 呼吸试验仪的使用于1983年推出,作为血液或尿液检测的替代品.
- 2015年,为17种精神活性物质制定了法定血度限制,包括娱乐性药物和处方药,取代了对药物DUID病例的临床损伤证据的依赖.
结论:
- 英国的立法逐渐朝着酒精和毒品影响驾驶的客观,可衡量的限制方向发展.
- 这些立法变化旨在通过简化起诉和标准化对DUI和DUID违法行为的执法来提高道路安全.
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
138
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
138
CNS Depressants: Alcohol and Nicotine
170
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
170
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Sight Distance in a Vertical Curve
32
Sight distance on vertical curves is critical in roadway design. It ensures drivers can see far enough ahead to identify and respond to hazards effectively. This directly impacts safety, driver comfort, and the overall efficiency of the transportation network.Vertical curves are classified into crest and sag curves based on their geometry. For crest curves, sight distance is determined by the line of sight between a driver's eye and a small object on the road's surface. Design parameters for...
32
Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769


